Literature DB >> 3096953

Malignant transformation of NIH-3T3 and CV-1 cells by a helical mycoplasma, Spiroplasma mirum, strain SMCA.

H Kotani, D Phillips, G J McGarrity.   

Abstract

A helical mycoplasma, Spiroplasma mirum strain SMCA, produced malignant transformation in mouse NIH 3T3 cells and monkey kidney CV-1 cells. The transformed cells exhibited morphological changes consistent with the transformed phenotype, grew in soft agar and produced tumors in athymic and BALB/c mice. Transmission electron microscopy revealed structures morphologically similar to mycoplasmas present in the cytoplasm of transformed but not untransformed 3T3 cells. The time of inoculation of S. mirum SMCA to 3T3 cells and the passage level of 3T3 cells affected transformation.

Entities:  

Mesh:

Year:  1986        PMID: 3096953     DOI: 10.1007/bf02621093

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  20 in total

1.  SUCKLING MOUSE CATARACT AGENT.

Authors:  H F CLARK
Journal:  J Infect Dis       Date:  1964-12       Impact factor: 5.226

2.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma.

Authors:  J G Tully; R F Whitcomb; H F Clark; D L Williamson
Journal:  Science       Date:  1977-03-04       Impact factor: 47.728

Review 4.  Molecular biology and genetics of mycoplasmas (Mollicutes).

Authors:  S Razin
Journal:  Microbiol Rev       Date:  1985-12

5.  Insect cell cultures in the study of attachment and pathogenicity of spiroplasmas and mycoplasmas.

Authors:  T Steiner; G J McGarrity; J M Bové; D M Phillips; M Garnier
Journal:  Ann Microbiol (Paris)       Date:  1984 Jan-Feb

6.  Rabbit lens cell cultures in the characterization of Spiroplasma mirum pathogenicity.

Authors:  G J McGarrity; F Megraud; L Gamon
Journal:  Ann Microbiol (Paris)       Date:  1984 Mar-Apr

7.  Cultivation and partial characterization of spiroplasmas in cell cultures.

Authors:  T Steiner; G J McGarrity; D M Phillips
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

8.  Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells.

Authors:  R G Greig; T P Koestler; D L Trainer; S P Corwin; L Miles; T Kline; R Sweet; S Yokoyama; G Poste
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Localization and persistence of spiroplasmas in an experimental brain infection in suckling rats.

Authors:  J G Tully; F O Bastian; D L Rose
Journal:  Ann Microbiol (Paris)       Date:  1984 Jan-Feb

10.  Survey of plasmids in various mycoplasmas.

Authors:  R Harasawa; M F Barile
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec
View more
  5 in total

1.  Mycoplasma infections and different human carcinomas.

Authors:  S Huang; J Y Li; J Wu; L Meng; C C Shou
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Growth of mycoplasma transformed tTN129 cells depends on IGF-I.

Authors:  L T Van der Ven; L H Rademakers; A F Angulo; J C Giltay; I Wills; G H Jansen; I M Prinsen; A G Rombouts; P J Roholl; W Den Otter
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

3.  Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation.

Authors:  S Tsai; D J Wear; J W Shih; S C Lo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

4.  Elimination of mycoplasmas from cell cultures by a novel soft agar technique.

Authors:  H Kotani; G Butler; D Heggan; G J McGarrity
Journal:  In Vitro Cell Dev Biol       Date:  1991-06

5.  Alteration of gene expression profiles during mycoplasma-induced malignant cell transformation.

Authors:  Shimin Zhang; Shien Tsai; Shyh-Ching Lo
Journal:  BMC Cancer       Date:  2006-05-04       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.